Gap shares plummet as retailer says tariffs could cost between $100 and $150 million

Gap shares plummet as retailer says tariffs could cost between 0 and 0 million


People walk past the entrance of a Gap store in Paris, France, July 1, 2021.

Sarah Meyssonnier | Reuters

Gap said new tariffs could impact its business by $100 million to $150 million, if they remain in effect, the company said Thursday when announcing fiscal first-quarter earnings. 

Shares fell more than 15% in after-hours trading.

In a news release, Gap said new 30% duties on imports from China and a 10% levy on imports from most other countries will cost the company between $250 million to $300 million without mitigation efforts. For now, it’s leaving that impact out of its guidance. 

The company said it’s planning to mitigate those costs by diversifying its supply chain and reducing its exposure to China so the impact is expected to be between $100 million and $150 million, which will likely show up on the balance sheet in the back half of the year. 

“Based on what we know today, we do not expect there to be meaningful price increases or impact to our consumer,” CEO Richard Dickson told CNBC in an interview. “I’ve talked about this often: We truly believe that strong brands can win in any market. It’s a big industry. It’s a big market. Obviously we’re a big player with market share, but as we look ahead, we see the potential to further market our brands and gain share.”

Beyond tariffs, Gap issued fiscal first-quarter results that beat expectations on the top and bottom lines.

Here’s how the apparel company performed compared with what Wall Street was anticipating, based on a survey of analysts by LSEG:

  • Earnings per share: 51 cents vs. 45 cents expected
  • Revenue: $3.46 billion vs. $3.42 billion expected

The company’s reported net income for the three-month period that ended May 3 was $193 million, or 51 cents per share, compared with $158 million, or 41 cents per share, a year earlier. 

Sales rose to $3.46 billion, up about 2% from $3.39 billion a year earlier.

Gap’s guidance was largely in line with consensus, but its gross margin forecast came in weaker than expected. It’s expecting full-year sales to grow between 1% and 2%, in line with expectations of up 1.3%, according to LSEG.

For the current quarter, it expects sales to be flat, compared with expectations of 0.2% growth, according to LSEG. It’s expecting its gross margin to be 41.8%, weaker than the 42.5% that StreetAccount had expected. 

In March, before President Donald Trump issued new tariffs on most parts of the world, the company was expecting a minimal impact from the duties. But three months later, it’s in a different position.

In March, Gap said it manufactures less than 10% of its products from China, which is seeing a 30% new tariff since Trump took office, but it now expects the country to represent less than 3% of its sourcing by the end of the year.

Its two largest trading partners are Vietnam and Indonesia, where Gap manufactured 27% and 19% of its products in fiscal 2024, respectively, according to its most recent annual filing. Vietnam is facing a potential 46% reciprocal tariff and, if that duty remains in effect, it could have a significant impact on Gap’s income. 

Trump’s trade war is throwing a wrench into Dickson’s plans to turn around the legacy retailer — efforts that are well underway and continuing to bear fruit. 

During the quarter, comparable sales grew 2%, essentially in line with expectations of 1.8%, according to StreetAccount. Gross margin, and operating margin also came in higher than expected. 

Here’s a closer look at each brand’s performance. 

  • Old Navy: Gap’s largest and most important brand notched sales of $2 billion, up 3% compared to last year, with comparable sales up 3%, ahead of expectations of 2.1%, according to StreetAccount. 
  • Gap: The company’s namesake banner saw sales of $724 million, up 5% compared to last year, with comparable sales up 5%, ahead of expectations of 3.4%. Dickson has focused much of his turnaround efforts on the Gap brand, and it’s been a standout performer over the last couple of quarters. 
  • Banana Republic: The safari chic brand is still seeing troubles with sales down 3% to $428 million, and comparable sales flat, compared with expectations of 1.5% growth. The company said it remains focused on improving the brand. 
  • Athleta: The athleisure brand has also been a drag on Gap’s overall performance with sales down 6% to $308 million and comparable sales down 8%. The figures were not comparable to consensus estimates. The company warned improvements at Athleta “will take time.”



Source

Gen Z and social media are helping men’s makeup go mainstream. The beauty industry is trying to capitalize
Business

Gen Z and social media are helping men’s makeup go mainstream. The beauty industry is trying to capitalize

Pixdeluxe | E+ | Getty Images It often starts small. A dab of concealer. A tinted moisturizer. Maybe a brow gel that goes from borrowed to bought. For many men, like Daniel Rankin, makeup has transformed from something taboo into a tool to make them look less tired and more put together. “I remember thinking, […]

Read More
Stellantis scraps Jeep, Chrysler plug-in hybrid vehicles amid EV slowdown, recall
Business

Stellantis scraps Jeep, Chrysler plug-in hybrid vehicles amid EV slowdown, recall

The Camp Jeep outdoor terrain at the New York International Auto Shown on April 16, 2025. Danielle DeVries | CNBC DETROIT — Stellantis is scrapping its plug-in hybrid electric Jeep SUVs and Chrysler minivan amid slowing EV sales, quality issues and weakened federal fuel economy requirements. The automaker on Friday said the decision to end […]

Read More
Amazon Pharmacy starts offering Novo Nordisk’s Wegovy weight-loss pill
Business

Amazon Pharmacy starts offering Novo Nordisk’s Wegovy weight-loss pill

Close-up of a hand holding a cellphone displaying the Amazon Pharmacy system, Lafayette, California, September 15, 2021.  Smith Collection | Gado | Getty Images Amazon announced Friday it now offers Novo Nordisk‘s Wegovy weight-loss pill through its digital pharmacy. Novo Nordisk began rolling out an oral version of its injectable obesity drug Wegovy in the […]

Read More